Clinical Performance of the Low Profile Zenith Alpha Abdominal Endovascular Graft: 2 Year Results from the ZEPHYR Registry

CONCLUSION: While treatment success is comparable with other commercially available grafts, the rate of limb complications at 2 years is concerning. The manufacturer’s instructions for use should be closely followed. Further studies are necessary to investigate the root cause of the increased rate of limb complications with the Zenith Alpha Abdominal Endovascular …